CLINICAL AND PHARMACOECONOMICAL EFFICIENCY OF CEFOPERAZONE + SULBACTAM IN CHILDREN, SUFFERING FROM CYSTIC FIBROSIS

Por E.B. Pavlinova, A.P. Breil', T.I. Safonova, S.G. Yurovsky
Publicado em 2006-12-01

ESTIMATION OF THE MODERN MUCOLYTIC THERAPY EFFICACY IN CHILDREN, SUFFERING FROM MUCOVISCIDOSIS (TWO YEAR EXPERIENCE OF DORNASE ALFA APPLICATION)

Por E.B. Pavlinova, A.G. Mingairova, T.I. Safonova, T.Yu. Korneyeva
Publicado em 2007-03-01

Possibilities of computed bronchophonography in the diagnosis of external respiratory dysfunction in patients with cystic fibrosis

Por E. B. Pavlinova, T. I. Safonova, I. A. IKirshina, A. G. Mingairova, N. Yu. Vlasenko, N. A. Polyanskaya
Publicado em 2016-11-01

Genetic Determination of Bronchopulmonary Dysplasia Formation: Pros and Cons

Por V. K. Pozharishchenskaya, I. V. Davydova, K. V. Savostianov, L. S. Namazova-Baranova, E. B. Pavlinova, A. V. Pushkov
Publicado em 2017-05-01

The role of polymorphism of antioxidative activity genes in the formation of disabling pathology of the central nervous system in preterm newborns

Por O. A. Savchenko, E. B. Pavlinova, N. A. Polyanskaya, I. A. Kirshina, E. I. Kurmasheva, А. A. Gubich
Publicado em 2020-11-01

Prognostic value of heart failure biomarkers in the assessment of cardiac dysfunction in the fetus and newborn

Por O. A. Savchenko, E. B. Pavlinova, N. A. Polyanskaya, I. A. Kirshina, A. A. Gubich, Yu. V. Chuprik
Publicado em 2021-05-01

The capability of chest computed tomography in the diagnosis of bronchopulmonary dysplasia outcomes in premature infants

Por E. B. Pavlinova, I. A. Kirshina, G. A. Sakhipova, A. Yu. Gorlina, O. A. Savchenko, N. Yu. Vlasenko, E. I. Kurmasheva, T. I. Safonova, T. V. Safronova
Publicado em 2019-07-01

Assessing physical development of children of the first year of life using information technologies

Por Zh. V. Gudinova, N. A. Skoblina, G. N. Zhernakova, O. V. Antonov, E. B. Pavlinova, Yu. S. Vaskovskaya, A. V. Zavyalova, N. Yu. Vlasenko, A. A. Komarova
Publicado em 2022-01-01